G. Alberts

发表

Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH‐SY5Y over human embryonic kidney 293 cells

W. Im, J. Pregenzer, G. Alberts, 2000, British journal of pharmacology.

One-step affinity purification of recombinant TATA binding proteins utilizing a modular protein interaction partner.

D. Shooltz, S. Triezenberg, G. Alberts, 2008, Protein expression and purification.

Agonist-induced [35S]GTPγS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor

W. Im, J. Pregenzer, G. Alberts, 1997, Neuroscience Letters.

Chloride Channel Expression with the Tandem Construct of α6-β2 GABAA Receptor Subunit Requires a Monomeric Subunit of α6 or γ2 (*)

G. Dillon, W. Im, J. Pregenzer, 1995, The Journal of Biological Chemistry.

Contributions of cysteine 114 of the human D3 dopamine receptor to ligand binding and sensitivity to external oxidizing agents

Glen L Alberts, Jeffrey F Pregenzer, Wha Bin Im, 1998, British journal of pharmacology.

Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds.

W. Im, C. Chio, G. Alberts, 2001, Molecular pharmacology.

Cloning of serotonin 5-HT1 receptor subtypes from the chimpanzee, gorilla and Rhesus monkey and their agonist-induced guanosine 5′γ 35S triphosphate binding

J. Slightom, W. Im, J. Pregenzer, 2000, Neuroscience Letters.

Differential pharmacology between the guinea‐pig and the gorilla 5‐HT1D receptor as probed with isochromans (5‐HT1D‐selective ligands)

J. Slightom, M. D. Ennis, R. Hoffman, 1999, British journal of pharmacology.

Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).

P. Slattum, L. Bhoite, Liisa Valppu, 2011, Journal of medicinal chemistry.

A unique phenotype of 5‐HT2C, agonist‐induced GTPγ35S binding, transferable to 5‐HT2A and 5‐HT2B, upon swapping intracellular regions

J. Slightom, W. Im, C. Chio, 2003, British journal of pharmacology.

Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors

J. Slightom, W. Im, J. Pregenzer, 1997, Neuroscience Letters.

Discovery of a protein sequence in the N-terminal region of the human neuronal α7 nicotinic acetylcholine receptor involved in homomeric interactions.

J. Slightom, W. Im, C. Chio, 2002, Neuroscience Letters.

Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells

W. Im, J. Pregenzer, G. S. Gill, 1999 .

Efficient functional coupling of the human D3 dopamine receptor to Go subtype of G proteins in SH‐SY5Y cells

J. Slightom, J L Slightom, P G Zaworski, 1999, British journal of pharmacology.

cient functional coupling of the human D 3 dopamine receptor to Go subtype of G proteins in SH-SY 5 Y cells 1

J. Slightom, W. Im, P. Zaworski, 1999 .

Positive allosteric modulator of the human 5-HT2C receptor.

D. Dinh, W. Im, C. Chio, 2003, Molecular pharmacology.

Identification of transmembrane regions critical for ligand binding to the human D3 dopamine receptor using various D3/D1 transmembrane chimeras.

W. Im, J. Pregenzer, G. Alberts, 1998, Molecular pharmacology.

Agonist-induced GTPgamma35S binding mediated by human 5-HT(2C) receptors expressed in human embryonic kidney 293 cells.

W. Im, J. Pregenzer, P. Zaworski, 1999, European journal of pharmacology.